Csenge Advisory Group Edwards Lifesciences Corp Transaction History

Csenge Advisory Group

$1.97 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$84.3 - $94.31 $1,180 - $1,320	-14 Reduced 0.4%	3,515 $324,000
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $27,637 - $36,408	-381 Reduced 9.74%	3,529 $337,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $149,893 - $188,879	-2,429 Reduced 38.32%	3,910 $298,000
Q3 2023 Nov 01, 2023	SELL	$69.28 - $93.38 $185,601 - $250,165	-2,679 Reduced 29.71%	6,339 $439,000
Q2 2023 Jul 20, 2023	BUY	$81.41 - $94.33 $44,449 - $51,504	546 Added 6.44%	9,018 $850,000
Q1 2023 May 01, 2023	BUY	$74.26 - $84.51 $3,787 - $4,310	51 Added 0.61%	8,472 $700,000
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $20,899 - $26,756	-306 Reduced 3.51%	8,421 $628,000
Q3 2022 Oct 04, 2022	BUY	$82.37 - $107.29 $37,395 - $48,709	454 Added 5.49%	8,727 $721,000
Q2 2022 Jul 27, 2022	SELL	$86.5 - $128.27 $9,255 - $13,724	-107 Reduced 1.28%	8,273 $787,000
Q1 2022 May 09, 2022	BUY	$101.96 - $128.34 $110,728 - $139,377	1,086 Added 14.89%	8,380 $986,000
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $48,717 - $59,851	-458 Reduced 5.91%	7,294 $764,000
Q3 2021 Oct 20, 2021	BUY	$102.91 - $122.75 $47,132 - $56,219	458 Added 6.28%	7,752 $870,000
Q2 2021 Jul 21, 2021	BUY	$83.84 - $104.76 $360,595 - $450,572	4,301 Added 143.7%	7,294 $764,000
Q1 2021 Apr 28, 2021	SELL	$78.68 - $90.67 $7,710 - $8,885	-98 Reduced 3.17%	2,993 $257,000
Q4 2020 Jan 26, 2021	SELL	$71.69 - $91.23 $5,376 - $6,842	-75 Reduced 2.37%	3,091 $282,000
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $3,695 - $4,809	-55 Reduced 1.71%	3,166 $249,000
Q2 2020 Jul 17, 2020	BUY	$57.54 - $76.95 $185,336 - $247,855	3,221 New	3,221 $223,000
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $6,450 - $7,914	-139 Closed	0 $0
Q3 2018 Nov 19, 2018	SELL	$45.7 - $58.03 $59,410 - $75,439	-1,300 Reduced 90.34%	139 $20,000
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $61,085 - $73,820	1,439 New	1,439 $211,000

Others Institutions Holding EW

# of Institutions

1,354

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.54 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.7 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.29 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.91 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$981 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account